00719.HK
Shandong Xinhua Pharmaceutical Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 5.65
+0.53%Margins
Gross margin
17.8%
EBITDA margin
5.2%
EBIT margin
3.3%
Net margin
2.5%
FCF margin
4.6%
4.1%
Return on equity
2.3%
Return on assets
3.8%
Return on invested capital
0.93x
Asset turnover
HKD 543.3M
Cash from operations
HKD 2.53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026